Alvotech

1
NAS:ALVO (Luxembourg)  
$ 14.15 +0.5 (+3.66%) 10:08 PM EST
At Loss
Volume:
248.34K
Avg Vol (2M):
270.33K
Also Trade In:
Volume:
248.34K
At Loss
Avg Vol (2M):
270.33K

Business Description

Description
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 0.01
Equity-to-Asset -0.98
Debt-to-Equity -1.15
Debt-to-EBITDA -2.18
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.82
Distress
Grey
Safe
Beneish M-Score -3.25
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 95.08
9-Day RSI 77.72
14-Day RSI 64.15
6-1 Month Momentum % 46.2
12-1 Month Momentum % 34.55

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.75
Quick Ratio 0.46
Cash Ratio 0.04
Days Inventory 173.59
Days Sales Outstanding 113.8
Days Payable 116.23

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.1
Shareholder Yield % -10.13
Name Current Vs Industry Vs History
Gross Margin % -75.93
Operating Margin % -388.11
Net Margin % -603.42
FCF Margin % -392.26
ROA % -60.72
ROIC % -37.97
ROC (Joel Greenblatt) % -164.01
ROCE % -73.01

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 38.53
EV-to-EBIT -9.42
EV-to-EBITDA -9.89
EV-to-Revenue 53.38
EV-to-FCF -13.61
Earnings Yield (Greenblatt) % -10.62
FCF Yield % -9.07